{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:29:11Z","timestamp":1789630151163,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comprehensive Psychiatry"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.comppsych.2016.12.008","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T12:31:18Z","timestamp":1483619478000},"page":"27-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Decreased S100B serum levels after treatment in bipolar patients in a manic phase"],"prefix":"10.1016","volume":"74","author":[{"given":"Meng-Chang","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiao-Lai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.comppsych.2016.12.008_bb0005","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jpsychires.2006.07.013","article-title":"Serum S100B and antioxidant enzymes in bipolar patients","volume":"41","author":"Andreazza","year":"2007","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jad.2008.04.013","article-title":"Oxidative stress markers in bipolar disorder: a meta-analysis","volume":"111","author":"Andreazza","year":"2008","journal-title":"J Affect Disord"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.psychres.2014.04.005","article-title":"An updated meta-analysis of oxidative stress markers in bipolar disorder","volume":"218","author":"Brown","year":"2014","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0020","doi-asserted-by":"crossref","first-page":"780645","DOI":"10.1155\/2010\/780645","article-title":"Mood disorders are glial disorders: evidence from in vivo studies","volume":"2010","author":"Schroeter","year":"2010","journal-title":"Cardiovasc Psychiatry Neurol"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jad.2015.05.037","article-title":"Cellular models to study bipolar disorder: a systematic review","volume":"184","author":"Viswanath","year":"2015","journal-title":"J Affect Disord"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jad.2014.10.045","article-title":"Thiobarbituric acid reactive substances (TBARS) is a state biomarker of oxidative stress in bipolar patients in a manic phase","volume":"173","author":"Tsai","year":"2015","journal-title":"J Affect Disord"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/jnr.20280","article-title":"Peroxide detoxification by brain cells","volume":"79","author":"Dringen","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","article-title":"The role of oxidative stress in neurodegenerative diseases","volume":"24","author":"Kim","year":"2015","journal-title":"Exp Neurobiol"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pneurobio.2004.02.001","article-title":"Astrocyte apoptosis: implications for neuroprotection","volume":"72","author":"Takuma","year":"2004","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0050","doi-asserted-by":"crossref","first-page":"708306","DOI":"10.1155\/2015\/708306","article-title":"Disruption in the blood\u2013brain barrier: the missing link between brain and body inflammation in bipolar disorder?","volume":"2015","author":"Patel","year":"2015","journal-title":"Neural Plast"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0055","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1042\/BST20140319","article-title":"The blood\u2013brain barrier endothelium: a target for pro-inflammatory cytokines","volume":"43","author":"Rochfort","year":"2015","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0060","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/0271678X15616978","article-title":"Drugs of abuse and blood\u2013brain barrier endothelial dysfunction: a focus on the role of oxidative stress","volume":"36","author":"Sajja","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-227X-12-13","article-title":"Clinical validation of S100B use in management of mild head injury","volume":"12","author":"Calcagnile","year":"2012","journal-title":"BMC Emerg Med"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0070","doi-asserted-by":"crossref","first-page":"379071","DOI":"10.1155\/2015\/379071","article-title":"Biomarkers of brain damage: S100B and NSE concentrations in cerebrospinal fluid--a normative study","volume":"2015","author":"Hajdukova","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00701-009-0463-6","article-title":"Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics","volume":"152","author":"Kovesdi","year":"2010","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0080","first-page":"261","article-title":"Pathophysiologic aspects of S-100beta protein: a new biological marker of brain pathology","volume":"57","author":"Beaudeux","year":"1999","journal-title":"Ann Biol Clin"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0085","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jemt.10296","article-title":"Intracellular and extracellular roles of S100 proteins","volume":"60","author":"Donato","year":"2003","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0090","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-5793(00)02301-2","article-title":"Immunocontent and secretion of S100B in astrocyte cultures from different brain regions in relation to morphology","volume":"486","author":"Pinto","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0095","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0361-9230(95)00040-2","article-title":"The S100 protein family: history, function, and expression","volume":"37","author":"Zimmer","year":"1995","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0100","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tins.2015.08.003","article-title":"The molecular constituents of the blood\u2013brain barrier","volume":"38","author":"Chow","year":"2015","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0105","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1074\/jbc.M115.695478","article-title":"Astrocyte resilience to oxidative stress induced by insulin-like growth factor I (IGF-I) involves preserved AKT (protein kinase B) activity","volume":"291","author":"Davila","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0110","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1007\/s12035-015-9497-3","article-title":"Dehydroascorbic acid promotes cell death in neurons under oxidative stress: a protective role for astrocytes","volume":"53","author":"Garcia-Krauss","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0014-5793(99)00451-2","article-title":"Astrocytes enhance radical defence in capillary endothelial cells constituting the blood\u2013brain barrier","volume":"449","author":"Schroeter","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.coph.2015.09.010","article-title":"Glial-endothelial crosstalk regulates blood\u2013brain barrier function","volume":"26","author":"Cheslow","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0006-8993(02)02586-6","article-title":"Serum S-100beta as a possible marker of blood\u2013brain barrier disruption","volume":"940","author":"Kapural","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2003.12.008","article-title":"Peripheral markers of blood\u2013brain barrier damage","volume":"342","author":"Marchi","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0135","first-page":"109","article-title":"Peripheral markers of brain damage and blood\u2013brain barrier dysfunction","volume":"21","author":"Marchi","year":"2003","journal-title":"Restor Neurol Neurosci"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/bdcb41f2-a320-4401-a6ab-86e71738597e","article-title":"Extracranial sources of S100B do not affect serum levels","volume":"5","author":"Pham","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0145","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.jpsychires.2013.07.005","article-title":"S100B-immunopositive astrocytes and oligodendrocytes in the hippocampus are differentially afflicted in unipolar and bipolar depression: a postmortem study","volume":"47","author":"Gos","year":"2013","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0150","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0006-3223(00)00950-1","article-title":"Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells","volume":"48","author":"Rajkowska","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0155","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2174\/13894501113149990014","article-title":"Serum S100B represents a new biomarker for mood disorders","volume":"14","author":"Schroeter","year":"2013","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0160","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0924-977X(02)00029-9","article-title":"Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study","volume":"12","author":"Machado-Vieira","year":"2002","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0165","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1515\/cclm-2013-0978","article-title":"Peripheral blood lymphocytes from patients with bipolar disorder demonstrate apoptosis and differential regulation of advanced glycation end products and S100B","volume":"52","author":"Moutsatsou","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0170","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1038\/npp.2014.81","article-title":"Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients","volume":"39","author":"Jakobsson","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0175","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/00001756-200209160-00021","article-title":"S100B is increased in mood disorders and may be reduced by antidepressive treatment","volume":"13","author":"Schroeter","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0180","article-title":"The prognostic value of serum neuron-specific enolase in traumatic brain injury: systematic review and meta-analysis","volume":"9","author":"Cheng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1651-2227.2002.tb01630.x","article-title":"Brain damage markers in children. Neurobiological and clinical aspects","volume":"91","author":"Leviton","year":"2002","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0190","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/jnnp.2006.093427","article-title":"Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones","volume":"77","author":"Steiner","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0195","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.neuroscience.2010.03.010","article-title":"Haloperidol and clozapine decrease S100B release from glial cells","volume":"167","author":"Steiner","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neulet.2007.05.016","article-title":"Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects","volume":"421","author":"Machado-Vieira","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0205","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s11064-013-1036-x","article-title":"Reduced serum levels of neuron specific enolase (NSE) in drug-naive subjects with major depression and bipolar disorder","volume":"38","author":"Wiener","year":"2013","journal-title":"Neurochem Res"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0210","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/glia.22811","article-title":"Pharmacologic heat shock protein 70 induction confers cytoprotection against inflammation in gliovascular cells","volume":"63","author":"Kacimi","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0215","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s00018-004-4464-6","article-title":"Hsp70 chaperones: cellular functions and molecular mechanism","volume":"62","author":"Mayer","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0220","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/02656730500069955","article-title":"The role of heat shock proteins Hsp70 and Hsp27 in cellular protection of the central nervous system","volume":"21","author":"Franklin","year":"2005","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0225","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1039\/C4FO00761A","article-title":"Allicin protects spinal cord neurons from glutamate-induced oxidative stress through regulating the heat shock protein 70\/inducible nitric oxide synthase pathway","volume":"6","author":"Liu","year":"2015","journal-title":"Food Funct"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0230","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/jnc.12781","article-title":"Therapeutic inducers of the HSP70\/HSP110 protect mice against traumatic brain injury","volume":"130","author":"Eroglu","year":"2014","journal-title":"J Neurochem"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0235","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1528-1167.2012.03459.x","article-title":"Neurofilament heavy chain and heat shock protein 70 as markers of seizure-related brain injury","volume":"53","author":"Rejdak","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0240","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/acps.12417","article-title":"Damage-associated molecular patterns and immune activation in bipolar disorder","volume":"132","author":"Stertz","year":"2015","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0245","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.jpsychires.2013.07.018","article-title":"Pattern of heat shock factor and heat shock protein expression in lymphocytes of bipolar patients: increased HSP70-glucocorticoid receptor heterocomplex","volume":"47","author":"Bei","year":"2013","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0250","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neulet.2009.09.025","article-title":"TAAR 6 and HSP-70 variations associated with bipolar disorder","volume":"465","author":"Pae","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0255","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.coph.2006.10.001","article-title":"p11 (S100A10)--an inducible adaptor protein that modulates neuronal functions","volume":"7","author":"Svenningsson","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0260","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.biopsych.2010.04.029","article-title":"A role for p11 in the antidepressant action of brain-derived neurotrophic factor","volume":"68","author":"Warner-Schmidt","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0265","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1017\/S1461145711000940","article-title":"Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression","volume":"15","author":"Melas","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0270","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrn3564","article-title":"p11 and its role in depression and therapeutic responses to antidepressants","volume":"14","author":"Svenningsson","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0275","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/mp.2010.3","article-title":"Translational research in bipolar disorder: emerging insights from genetically based models","volume":"15","author":"Chen","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0280","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0285","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0920-9964(99)00114-0","article-title":"Schizophrenia and bipolar disorder: findings from studies of the Stanley Foundation brain collection","volume":"39","author":"Knable","year":"1999","journal-title":"Schizophr Res"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0290","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/sj.mp.4000696","article-title":"Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley neuropathology consortium","volume":"5","author":"Johnston-Wilson","year":"2000","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0295","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/glia.22716","article-title":"Myelination, oligodendrocytes, and serious mental illness","volume":"62","author":"Haroutunian","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0300","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1503\/jpn.130277","article-title":"Evidence for morphological alterations in prefrontal white matter glia in schizophrenia and bipolar disorder","volume":"39","author":"Hercher","year":"2014","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0305","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/NDT.S72536","article-title":"Increased expression of retinoic acid-induced gene 1 in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression","volume":"11","author":"Haybaeck","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0310","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1212\/01.WNL.0000123092.97047.B1","article-title":"Serum S100beta increases in marathon runners reflect extracranial release rather than glial damage","volume":"62","author":"Hasselblatt","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0315","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/mp.2009.87","article-title":"Elevated S100B levels in schizophrenia are associated with insulin resistance","volume":"15","author":"Steiner","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0320","first-page":"323","article-title":"Negative correlation between serum S100B and Leptin levels in schizophrenic patients during treatment with clozapine and risperidone: preliminary evidence","volume":"15","author":"Hendouei","year":"2016","journal-title":"Iran J Pharm Res"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0325","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0920-9964(02)00383-3","article-title":"Serum S100B is increased during early treatment with antipsychotics and in deficit schizophrenia","volume":"62","author":"Schroeter","year":"2003","journal-title":"Schizophr Res"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0330","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1757-7241-21-52","article-title":"S100B levels are affected by older age but not by alcohol intoxication following mild traumatic brain injury","volume":"21","author":"Calcagnile","year":"2013","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0335","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12916-015-0529-7","article-title":"Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies","volume":"13","author":"Fernandes","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0340","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/mp.2015.54","article-title":"Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis","volume":"21","author":"Munkholm","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0345","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jad.2014.11.044","article-title":"BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis","volume":"174","author":"Polyakova","year":"2015","journal-title":"J Affect Disord"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0350","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3389\/fncel.2015.00489","article-title":"Changes in Astroglial markers in a maternal immune activation model of schizophrenia in Wistar rats are dependent on sex","volume":"9","author":"de Souza","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0355","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1471-244X-13-146","article-title":"Levels of S100B are raised in female patients with schizophrenia","volume":"13","author":"O'Connell","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0360","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pnpbp.2012.12.001","article-title":"Interleukin-6-induced S100B secretion is inhibited by haloperidol and risperidone","volume":"43","author":"de Souza","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.comppsych.2016.12.008_bb0365","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neulet.2009.06.019","article-title":"Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics","volume":"462","author":"Qi","year":"2009","journal-title":"Neurosci Lett"}],"container-title":["Comprehensive Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X16303273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X16303273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T09:51:13Z","timestamp":1536141073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010440X16303273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":73,"alternative-id":["S0010440X16303273"],"URL":"https:\/\/doi.org\/10.1016\/j.comppsych.2016.12.008","relation":{},"ISSN":["0010-440X"],"issn-type":[{"value":"0010-440X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased S100B serum levels after treatment in bipolar patients in a manic phase","name":"articletitle","label":"Article Title"},{"value":"Comprehensive Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.comppsych.2016.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}